Teriflunomid Devatis 14 mg
Teriflunomid Devatis 14 mg is a medicine authorised by Swissmedic under authorisation number 69756. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 February 2025 and the authorisation is limited until 24 February 2030. ATC code L04AK02 places the medicine in the group Immunosuppressants.
| Authorisation number | 69756 |
|---|---|
| Name | Teriflunomid Devatis 14 mg |
| Full name | Teriflunomid Devatis 14 mg, Filmtabletten |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AK02 |
| First authorisation | 25 February 2025 |
| Authorisation validity | 24 February 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Teriflunomid Devatis 14 mg, Filmtabletten | B | 25 February 2025 |
| 2 | Teriflunomid Devatis 14 mg QOD, Filmtabletten | B | 25 February 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | L04AK02 | 01.99.0. | B |
| 2 | 84 | Tablette(n) | L04AK02 | 01.99.0. | B |
| 3 | 28 | Tablette(n) | L04AK02 | 01.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Teriflunomid Devatis 14 mg authorised in Switzerland?
Yes. Teriflunomid Devatis 14 mg is authorised by Swissmedic under authorisation number 69756, data as of 01 September 2026. The authorisation is limited until 24 February 2030.
Which dispensing category does Teriflunomid Devatis 14 mg have?
Teriflunomid Devatis 14 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Teriflunomid Devatis 14 mg?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.